How it works
Retatrutide is a triple-agonist peptide — it activates three metabolic receptors (GIP, GLP-1, and glucagon) involved in blood sugar, appetite, and energy use. In early research, triple agonists of this type have been reported to reduce appetite and produce substantial body-weight reduction in study models, along with effects on glucose and lipid metabolism.
For laboratory and research use only — not for human or veterinary consumption.
GLP-3RT (Retatrutide Analog) — Lyophilized Powder | For Research Use Only
GLP-3RT is a lyophilized synthetic triple agonist peptide analog (GLP-1 / GIP / glucagon receptors), supplied as a research-grade compound for in vitro and preclinical laboratory study.
Compound profile
A synthetic peptide acting as an agonist at three incretin and glucagon family receptors. Used in laboratory research models examining multi-receptor co-activation, intracellular signaling cascades, and metabolic pathway studies.
Specifications
Form: Lyophilized powder (sterile, aseptic fill). Purity: ≥99% by HPLC. Endotoxin testing: LAL method, batch-certified. Stability confirmed by mass spectrometry. COA available per lot.
Storage & handling
Lyophilized: store at -20°C for long-term stability; 2–8°C acceptable short-term. Protect from UV and humidity. Once reconstituted, store at 2–8°C and utilize within 28–30 days. Avoid repeated freeze-thaw cycles.
Regulatory notice
This product is supplied strictly for in vitro and preclinical laboratory research by qualified personnel. It has not been evaluated by the FDA or any equivalent regulatory authority. It is not approved for, nor intended for, human or veterinary use, clinical administration, or dietary supplementation. Not for resale or use outside of a controlled research environment.
Retatrutide Analog (GLP-3RT) – Research Peptide
Research Kit – 20% off 10+ vials (full box)